Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bison (also known as Bison Antioxidant Cough Syrup) is an Ayurvedic proprietary cough syrup developed and marketed by Juggat Pharma, the pharmaceutical division of Jagdale Industries. It is formulated as a holistic cough remedy combining several traditional herbal extracts, including Talisa Patra (Abies webbiana), Yashtimadhu (Glycyrrhiza glabra), Triphala (Terminalia chebula, Terminalia belerica, Emblica officinalis), Trikatu (Piper longum, Piper nigrum, Zingiber officinale), Haridra (Curcuma longa), Tulsi (Ocimum sanctum), and Pudina Satwa (Mentha piperita). The syrup is indicated for the relief of various types of cough (Kasa), chest congestion and dyspnea (Swasa), and hoarseness of voice (Swarabedha). It also acts as an antioxidant (Rasayana) and immune booster (Balya) to support respiratory wellness.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Bison.